Home LiteratureArticle Details
PMID: 41438882 Published · epublish English

Patient satisfaction after breast reconstruction in a high-risk breast cancer population.

JPRAS open ·Vol. 48 ·2026-03-00

Berben JA, Heuts EM, Piatkowski de Grzymala AA, Miseré RM, Gómez García EB, van Kuijk SMJ, Hebon, van der Hulst RRWJ

Abstract

Women with an elevated risk for breast cancer due to a BRCA1 or BRCA2 pathogenic variant can choose for surveillance or risk reducing mastectomy (RRM). Breast reconstruction improves quality of life (QoL). However, in this high-risk population, the effect of breast reconstruction on QoL nor the level of satisfaction afterward is widely researched. This cross-sectional study aimed to determine the long-term satisfaction level with breast reconstruction in a high-risk breast cancer population. Women who underwent breast reconstruction were invited to complete several online questionnaires including the BREAST-Q, SF-36, general questions on their health and DNA test results, and the course of diagnosis and treatment. In the analyses two groups were compared: patients with breast reconstruction after risk-reducing mastectomy (BRaRRM) and patients with breast reconstruction after breast cancer (BRaBC). About 935 participants completed all questionnaires of whom 535 underwent breast reconstruction and were included in this analysis. There was no difference between BREAST-Q "satisfaction with outcome" scales between the BRaRRM and BRaBC groups (60.9 vs 60.9). According to our multivariable linear regression analysis, higher age had a positive association with satisfaction with outcome, and both secondary and implant-based reconstruction were negatively associated with satisfaction with outcome (b = 0.21, b = -2.10, b = -5.83). RRM combined with breast reconstruction is a good option for women with high risk of breast cancer. No difference in the BREAST-Q satisfaction with outcome scale was observed between both groups. Age, type, and timing of reconstruction should be considered when deciding on RRM.

Keywords
BRCA-1/2 Breast reconstruction Breast cancer Genetic predisposition Prophylactic mastectomy Quality of life Risk reducing mastectomy
Article Info
Journal
JPRAS open
Abbr.
JPRAS Open
ISSN
2352-5878
Published
2026-03-00
Language
English
Country/Region
Netherlands
NLM ID
101680420
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com